Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease

Abstract

Elevated plasma dimethylglycine was associated with and improved risk prediction of mortality in patients with suspected or verified CHD. This relationship was stronger for death from cardiovascular, as compared with non-cardiovascular, causes.